Plancorp, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
Plancorp, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$486,568
+1.3%
4,777
+0.3%
0.03%0.0%
Q2 2023$480,516
+9.7%
4,7620.0%0.03%
+4.0%
Q1 2023$438,088
+1.5%
4,762
+0.1%
0.02%0.0%
Q4 2022$431,673
+17.6%
4,758
-1.5%
0.02%
+4.2%
Q3 2022$367,000
-11.6%
4,830
-1.6%
0.02%
-7.7%
Q2 2022$415,000
-19.1%
4,908
-16.0%
0.03%
-21.2%
Q1 2022$513,000
+0.6%
5,841
+0.2%
0.03%
+3.1%
Q4 2021$510,000
+6.9%
5,8300.0%0.03%
-3.0%
Q3 2021$477,000
-10.3%
5,8300.0%0.03%
-21.4%
Q2 2021$532,000
+6.8%
5,8300.0%0.04%
-61.8%
Q1 2021$498,000
-16.4%
5,830
-7.6%
0.11%
-25.2%
Q4 2020$596,000
+8.6%
6,3090.0%0.15%
-12.0%
Q3 2020$549,000
-4.0%
6,309
-3.7%
0.17%
-2.9%
Q2 2020$572,000
+5.7%
6,552
-0.1%
0.17%
-17.7%
Q1 2020$541,000
-15.5%
6,559
-2.9%
0.21%
+6.6%
Q4 2019$640,000
+8.1%
6,756
-0.9%
0.20%
-13.3%
Q3 2019$592,000
-9.5%
6,816
-4.8%
0.23%
-12.7%
Q2 2019$654,000
-9.4%
7,162
-4.6%
0.26%
-5.1%
Q1 2019$722,000
+17.4%
7,505
+4.7%
0.27%
-2.2%
Q4 2018$615,000
-5.5%
7,166
-5.2%
0.28%
+9.0%
Q3 2018$651,000
+12.6%
7,561
-1.2%
0.26%
+10.8%
Q2 2018$578,000
+79.5%
7,656
+104.2%
0.23%
+143.2%
Q3 2017$322,000
+15.8%
3,7500.0%0.10%
+17.3%
Q1 2017$278,000
-46.7%
3,750
-47.8%
0.08%
-45.6%
Q4 2016$522,000
+107.1%
7,179
+107.1%
0.15%
-50.7%
Q1 2016$252,000
-52.6%
3,466
-38.7%
0.30%
-46.0%
Q3 2014$532,000
+10.8%
5,657
+0.1%
0.56%
+71.5%
Q1 2014$480,000
+9.8%
5,654
+3.7%
0.33%
-14.9%
Q4 2013$437,0005,4510.38%
Other shareholders
NOVARTIS A G shareholders Q4 2013
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders